176 related articles for article (PubMed ID: 6168368)
21. Immunohistochemistry of germ cell and trophoblastic neoplasms.
Niehans GA; Manivel JC; Copland GT; Scheithauer BW; Wick MR
Cancer; 1988 Sep; 62(6):1113-23. PubMed ID: 2457424
[TBL] [Abstract][Full Text] [Related]
22. Human first trimester fetal ovaries express oncofetal antigens and steroid receptors.
Gould DA; Moscoso GJ; Young MP; Barton DP
J Soc Gynecol Investig; 2000; 7(2):131-8. PubMed ID: 10785614
[TBL] [Abstract][Full Text] [Related]
23. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
24. Oncofetal antigens in sacrococcygeal teratomas.
Kuhajda FP; Taxy JB
Arch Pathol Lab Med; 1983 May; 107(5):239-42. PubMed ID: 6188436
[TBL] [Abstract][Full Text] [Related]
25. Tumour markers in gynaecologic oncology.
Onsrud M
Scand J Clin Lab Invest Suppl; 1991; 206():60-70. PubMed ID: 1719611
[TBL] [Abstract][Full Text] [Related]
26. Tumor markers: how useful are they?
McIntire KR
Hosp Pract (Off Ed); 1984 Dec; 19(12):55-68. PubMed ID: 6209292
[No Abstract] [Full Text] [Related]
27. Oncofoetal antigens in cancer of the cervix and ovary.
Cauchi MN; Koh SH; Lim D; Hay DL
Br J Cancer; 1981 Sep; 44(3):403-9. PubMed ID: 6169360
[TBL] [Abstract][Full Text] [Related]
28. The role of tumor markers in gynecologic oncology.
Olt G; Berchuck A; Bast RC
Obstet Gynecol Surv; 1990 Sep; 45(9):570-7. PubMed ID: 1697940
[TBL] [Abstract][Full Text] [Related]
29. Clinical use of gynaecologic tumour markers.
Halila H; Alfthan H; Stenman UH
Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
[TBL] [Abstract][Full Text] [Related]
30. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
[TBL] [Abstract][Full Text] [Related]
31. Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Valerio MG; Harris CC; Trump BF
Cancer Res; 1986 Nov; 46(11):5730-7. PubMed ID: 2428482
[TBL] [Abstract][Full Text] [Related]
32. Radioimmunoassay and saturation analysis. Tumor-associated antigens.
Bagshawe KD
Br Med Bull; 1974 Jan; 30(1):68-73. PubMed ID: 4143181
[No Abstract] [Full Text] [Related]
33. The simultaneous expression of human chorionic gonadotropin and carcinoembryonic antigen in the female genital tract. Localization by immunocytochemistry.
Hayata T; Fenoglio CM; Crum CP; Richart RM
Diagn Gynecol Obstet; 1981; 3(4):309-14. PubMed ID: 7040010
[TBL] [Abstract][Full Text] [Related]
34. The detection and measurement of oncodevelopmental proteins in gynecological malignant disease.
Cerni C; Tatra G
Arch Gynecol; 1982; 231(2):159-65. PubMed ID: 6176191
[TBL] [Abstract][Full Text] [Related]
35. A primary lung carcinoma producing alpha-fetoprotein, carcinoembryonic antigen, and human chorionic gonadotropin. Immunohistochemical and biochemical studies.
Yoshimoto T; Higashino K; Hada T; Tamura S; Nakanishi K; Mitsunobu M; Uematsu K; Matsuoka T; Taketa K
Cancer; 1987 Dec; 60(11):2744-50. PubMed ID: 2445464
[TBL] [Abstract][Full Text] [Related]
36. [The place of tumor markers in breast and gynecologic neoplasms].
Gosselin P; Cazin JL; Demaille MC; Sulman C
Rev Fr Gynecol Obstet; 1988; 83(7-9):535-40. PubMed ID: 3057569
[TBL] [Abstract][Full Text] [Related]
37. Tumor markers for ovarian cancer.
Bhattacharya M; Barlow JJ
Int Adv Surg Oncol; 1979; 2():155-76. PubMed ID: 95453
[TBL] [Abstract][Full Text] [Related]
38. Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
Williams RR; McIntire KR; Waldmann TA; Feinleib M; Go VL; Kannel WB; Dawber TR; Castelli WP; McNamara PM
J Natl Cancer Inst; 1977 Jun; 58(6):1547-51. PubMed ID: 68118
[TBL] [Abstract][Full Text] [Related]
39. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study.
Nouwen EJ; Hendrix PG; Dauwe S; Eerdekens MW; De Broe ME
Am J Pathol; 1987 Feb; 126(2):230-42. PubMed ID: 3548400
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic significance of tumor markers for gynecologic malignancies].
Aoki D; Hirasawa A; Susumu N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
